|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.34 | 89.43 | 104.26 | 0.53 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Pharmaceuticals & Drugs
|
|
|
|
|
|
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
|
(Rs. in Million) | Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Audited / UnAudited | UnAudited | Audited | UnAudited | UnAudited | Net Sales | 0 | 0 | 0 | 0 | Total Expenditure | 1.09 | 1.34 | 1.22 | 1.42 | PBIDT (Excl OI) | -1.09 | -1.34 | -1.22 | -1.42 | Other Income | 0 | 0 | 0 | 0 | Operating Profit | -1.09 | -1.34 | -1.22 | -1.42 | Interest | 0 | 0 | 0 | 0 | Exceptional Items | 0 | 0 | 0 | 0 | PBDT | -1.09 | -1.34 | -1.22 | -1.42 | Depreciation | 0 | 0 | 0 | 0 | Profit Before Tax | -1.09 | -1.34 | -1.22 | -1.42 | Tax | 0 | 0 | 0 | 0 | Provisions and contingencies | 0 | 0 | 0 | 0 | Profit After Tax | -1.09 | -1.34 | -1.22 | -1.42 | Extraordinary Items | 0 | 0 | 0 | 0 | Prior Period Expenses | 0 | 0 | 0 | 0 | Other Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | Net Profit | -1.09 | -1.34 | -1.22 | -1.42 | Equity Capital | 43.89 | 43.89 | 43.89 | 43.89 | Face Value (IN RS) | 10 | 10 | 10 | 10 | Reserves | | | | | Calculated EPS | -0.25 | -0.31 | -0.28 | -0.32 | Calculated EPS (Annualised) | -0.99 | -1.22 | -1.11 | -1.29 | No of Public Share Holdings | 4,388,600.00 | 4,388,600.00 | 4,388,600.00 | 4,388,600.00 | % of Public Share Holdings | 100.00 | 100.00 | 100.00 | 100.00 | | | | | | PBIDTM% (Excl OI) | 0 | 0 | 0 | 0 | PBIDTM% | 0 | 0 | 0 | 0 | PBDTM% | 0 | 0 | 0 | 0 | PBTM% | 0 | 0 | 0 | 0 | PATM% | 0 | 0 | 0 | 0 | | Notes | Notes | Notes | Notes |
|
|
|
|
|
|